Newer type 2 diabetes drugs show heart protective quality in study
By Bill Berkrot | WASHINGTON WASHINGTON A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. The drugs, known as SGLT-2 inhibitors, work by removing blood sugar via the urine and include Astra’s Farxiga, Jardiance from […]